Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis

BACKGROUND: Transthyretin cardiac amyloidosis, also known as transthyretin cardiomyopathy (ATTR-CM) is a poorly-recognized disease with delayed diagnosis and poor prognosis. This nationwide population-based study aimed to identify disease manifestations, economic burden, and mortality of patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Suk-Chan, Nam, Jin Hyun, Lee, Seung-Ah, An, Dasom, Kim, Hye-Lin, Kwon, Sun-Hong, Lee, Eui-Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287852/
https://www.ncbi.nlm.nih.gov/pubmed/35840997
http://dx.doi.org/10.1186/s13023-022-02425-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287852/
https://www.ncbi.nlm.nih.gov/pubmed/35840997
http://dx.doi.org/10.1186/s13023-022-02425-3

Ejemplares similares